SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wicks Timothy A

(Last) (First) (Middle)
C/O PEAR THERAPEUTICS, INC.
200 STATE STREET, 13TH FLOOR

(Street)
BOSTON MA 02109

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/14/2022
3. Issuer Name and Ticker or Trading Symbol
Pear Therapeutics, Inc. [ PEAR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
No Securities Beneficially Owned. Exhibit 24 Power of Attorney filed herewith.
No securities are beneficially owned.
/s/ Stacie S. Aarestad, Attorney-in-fact 06/16/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

     KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes Ronan
O'Brien of Pear Therapeutics, Inc. (the "Company") and Stacie S. Aarestad of
Foley Hoag LLP, each acting singly, to execute and cause to be filed with the
United States Securities and Exchange Commission any and all documents or
filings, including any amendments thereto, required to be so filed. The
undersigned hereby grants to the attorney-in-fact full power and authority to
do and perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or
could do personally present, with full power of substitution, resubstitution
or revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing attorney-in-
fact, or such attorney-in-fact's substitute, in serving in such capacity at
the request of the undersigned, is not assuming, nor is the Company assuming,
any liability from the undersigned's responsibilities to comply with all
applicable laws, including Sections 13 and 16 of the Securities Exchange Act
of 1934 (the "Exchange Act").

     This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms
3, 4 and 5 in accordance with Section 16(a) of the Exchange Act with respect
to the undersigned's holdings of and transactions in securities issued by the
Company, (b) revocation by the undersigned in a signed writing delivered to
the Company and the foregoing attorney-in-fact and (c) as to any attorney-in-
fact individually, until such attorney-in-fact is no longer employed by the
Company or employed by or a partner at Foley Hoag LLP, or another law firm
representing the Company, as applicable.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 9th day of June, 2022.

/s/ Timothy A. Wicks
Name: Timothy A. Wicks